Back to Pulmonology
Pulmonologyv2004Evidence-Based

BODE Index for COPD Survival

Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.

Clinical Input Parameters

%
Range: 10 — 150 %
meters
Range: 0 — 1000 meters
kg/m²
Range: 10 — 50 kg/m²
Clinical Assessment
Awaiting Parameters
bode index score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The BODE Index for COPD Survival is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pulmonology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

BODE Index = FEV1 score + 6MWD score + mMRC score + BMI score. Total score ranges from 0-10 points with higher scores indicating worse prognosis.

Clinical Pearls & Practice Notes

  • Not intended for use during acute COPD exacerbations - use only in stable patients
  • Does not guide specific treatment decisions but provides prognostic information
  • Should be used in conjunction with clinical judgment and other prognostic factors
  • FEV1 percentage predicted should be based on appropriate reference equations for patient demographics
  • 6-minute walk test should be performed according to standardized protocols (ATS guidelines)
  • BMI component reflects the obesity paradox in COPD where lower BMI indicates worse prognosis
  • Originally developed and validated in outpatients with stable COPD
  • Has been validated across multiple populations and healthcare systems worldwide

Evidence & Literature Citations

  1. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
  2. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005 Dec;128(6):3810-6. doi: 10.1378/chest.128.6.3810.
  3. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005 Oct;26(4):630-6. doi: 10.1183/09031936.05.00045505.
  4. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.

Score Interpretation Ranges

Quartile 1 (Low Risk)0 – 2 pts

BODE Index 0-2 points

Quartile 2 (Moderate Risk)3 – 4 pts

BODE Index 3-4 points

Quartile 3 (High Risk)5 – 6 pts

BODE Index 5-6 points

Quartile 4 (Very High Risk)7 – 10 pts

BODE Index 7-10 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.